Concepedia

D Halter

DH

Statistics

Publications

4

Citations

938

H-Index

4

Active since

2006

Affiliations

University of Utah(Current)

University of Toronto

Leiden University Medical Center

University of California San Diego

Houston Institute for Clinical Research

D Halter is an author at University of Utah specializing in medicine, pharmacotherapy, and rheumatology.

Publications per year

2006–2017

4

Publications

4

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial

Arthur Kavanaugh, Gerald G. Krueger, Anna Beutler et al. · Annals of the Rheumatic Diseases · 2006 · 202 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

Désirée van der Heijde, Arthur Kavanaugh, Dafna D. Gladman et al. · Arthritis & Rheumatism · 2007 · 184 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

Désirée van der Heijde, Maxime Bréban, D Halter et al. · Lara D. Veeken · 2014 · 56 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

1–4 of 4